Display options
Share it on

Front Physiol. 2015 Nov 20;6:342. doi: 10.3389/fphys.2015.00342. eCollection 2015.

Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans.

Frontiers in physiology

Martin Adiels, Adil Mardinoglu, Marja-Riitta Taskinen, Jan Borén

Affiliations

  1. Department of Molecular and Clinical Medicine/Wallenberg Laboratory, University of Gothenburg Gothenburg, Sweden ; Health Metrics Unit, Sahlgrenska Academy, University of Gothenburg Gothenburg, Sweden.
  2. Department of Biology and Biological Engineering, Chalmers University of Technology Gothenburg, Sweden ; Science for Life Laboratory, KTH - Royal Institute of Technology Stockholm, Sweden.
  3. Heart and Lung Centre, Helsinki University Hospital and Research Programs' Unit, Diabetes & Obesity, University of Helsinki Helsinki, Finland.
  4. Department of Molecular and Clinical Medicine/Wallenberg Laboratory, University of Gothenburg Gothenburg, Sweden.

PMID: 26635628 PMCID: PMC4653309 DOI: 10.3389/fphys.2015.00342

Abstract

To develop novel strategies for prevention and treatment of dyslipidemia, it is essential to understand the pathophysiology of dyslipoproteinemia in humans. Lipoprotein metabolism is a complex system in which abnormal concentrations of various lipoprotein particles can result from alterations in their rates of production, conversion, and/or catabolism. Traditional methods that measure plasma lipoprotein concentrations only provide static estimates of lipoprotein metabolism and hence limited mechanistic information. By contrast, the use of tracers labeled with stable isotopes and mathematical modeling, provides us with a powerful tool for probing lipid and lipoprotein kinetics in vivo and furthering our understanding of the pathogenesis of dyslipoproteinemia.

Keywords: apoB; kinetics; multocomnpartmental modeling; stable isotopes; very low density lipoproteins

References

  1. Curr Opin Lipidol. 2014 Jun;25(3):200-6 - PubMed
  2. Circulation. 2004 Jan 6;109(1):42-6 - PubMed
  3. Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15430-5 - PubMed
  4. Int J Obes (Lond). 2011 Sep;35(9):1233-40 - PubMed
  5. Arterioscler Thromb Vasc Biol. 2010 May;30(5):1043-50 - PubMed
  6. PLoS One. 2015 Sep 30;10(9):e0138538 - PubMed
  7. Obesity (Silver Spring). 2010 Aug;18(8):1510-5 - PubMed
  8. J Intern Med. 2013 Jul;274(1):25-40 - PubMed
  9. Rapid Commun Mass Spectrom. 2010 Mar 15;24(5):586-92 - PubMed
  10. J Lipid Res. 1995 Jan;36(1):172-87 - PubMed
  11. Curr Opin Biotechnol. 2015 Aug;34:91-7 - PubMed
  12. J Lipid Res. 1999 Jan;40(1):1-16 - PubMed
  13. Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1225-36 - PubMed
  14. J Clin Invest. 1973 Jul;52(7):1578-85 - PubMed
  15. Diabetes. 2014 Jul;63(7):2394-401 - PubMed
  16. J Clin Invest. 2007 Jan;117(1):153-64 - PubMed
  17. Cell. 1987 Sep 11;50(6):831-40 - PubMed
  18. Diabetologia. 2012 Oct;55(10):2733-40 - PubMed
  19. Cell. 2015 May 21;161(5):971-87 - PubMed
  20. Obes Res. 2005 Jun;13(6):1008-16 - PubMed
  21. J Clin Endocrinol Metab. 2009 Mar;94(3):989-97 - PubMed
  22. Clin Chim Acta. 2014 Apr 20;431:131-42 - PubMed
  23. Curr Mol Med. 2005 May;5(3):297-308 - PubMed
  24. Atherosclerosis. 2015 Apr;239(2):483-95 - PubMed
  25. Diabetes. 2011 Jan;60(1):88-96 - PubMed
  26. J Lipid Res. 1984 Dec 1;25(12):1277-94 - PubMed
  27. J Clin Endocrinol Metab. 2014 Aug;99(8):E1427-35 - PubMed
  28. J Clin Invest. 1979 Jun;63(6):1262-73 - PubMed
  29. Math Med Biol. 2012 Dec;29(4):361-84 - PubMed
  30. Diabetologia. 2006 Apr;49(4):755-65 - PubMed
  31. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:5482-5 - PubMed
  32. Crit Rev Biomed Eng. 1982;8(3):195-222 - PubMed
  33. Clin Sci (Lond). 2004 Sep;107(3):233-49 - PubMed
  34. Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2330-7 - PubMed
  35. Metabolism. 1998 Apr;47(4):484-92 - PubMed
  36. Curr Opin Lipidol. 2006 Jun;17(3):238-46 - PubMed
  37. J Lipid Res. 2007 Aug;48(8):1746-53 - PubMed
  38. Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):621 - PubMed
  39. Int J Obes Relat Metab Disord. 2002 Sep;26(9):1151-8 - PubMed
  40. J Clin Invest. 2008 Oct;118(10):3247-59 - PubMed
  41. Diabetes. 1993 Jun;42(6):833-42 - PubMed
  42. J Clin Invest. 1979 Jun;63(6):1274-83 - PubMed
  43. J Lipid Res. 2011 Jun;52(6):1067-70 - PubMed
  44. Hepatology. 2003 May;37(5):1202-19 - PubMed
  45. Int J Biochem Cell Biol. 2005 Jun;37(6):1308-18 - PubMed
  46. IEEE Trans Biomed Eng. 2009 Sep;56(9):2156-66 - PubMed
  47. J Lipid Res. 2001 Sep;42(9):1346-67 - PubMed
  48. J Lipid Res. 2005 Jan;46(1):58-67 - PubMed
  49. Am J Clin Nutr. 2014 Jan;99(1):54-61 - PubMed
  50. J Clin Endocrinol Metab. 2014 Jan;99(1):E122-6 - PubMed
  51. Diabetologia. 2008 Nov;51(11):1947-53 - PubMed
  52. Aliment Pharmacol Ther. 2011 Aug;34(3):274-85 - PubMed
  53. Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2144-50 - PubMed
  54. Diabetologia. 2005 Jun;48(6):1207-15 - PubMed
  55. J Lipid Res. 2006 Aug;47(8):1607-19 - PubMed
  56. Diabetologia. 2007 Nov;50(11):2356-65 - PubMed
  57. Clin Sci (Lond). 2004 Sep;107(3):221-32 - PubMed
  58. Arterioscler Thromb Vasc Biol. 2015 Oct;35(10):2218-24 - PubMed
  59. J Lipid Res. 2002 Feb;43(2):223-33 - PubMed
  60. Curr Opin Lipidol. 2010 Jun;21(3):218-28 - PubMed
  61. Am J Physiol Endocrinol Metab. 2013 Oct 15;305(8):E1041-7 - PubMed
  62. Diabetologia. 2003 Jun;46(6):733-49 - PubMed
  63. Nat Commun. 2014;5:3083 - PubMed
  64. Atherosclerosis. 2012 May;222(1):222-8 - PubMed
  65. J Clin Endocrinol Metab. 2014 Nov;99(11):4281-90 - PubMed

Publication Types